|
⚲
|
| Alios Biopharma Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001380990 |
| Sale | 2008-12-23 ($34.2 M Offered, $30.2 M Sold) |
| Fund | |
| Phone | 6506355500 |
| Address | 260 East Grand Avenue, 2nd Floor South San Francisco, 94080 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Peter Hirth | |
| Kent Gossett | |
| Lawrence Blatt | |
| Leonid Beigelman | |
| Jack Nielsen | |
| Campbell Murray |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
BrewBilt Brewing Co
✚
|
0.0 | |
|
2150 Urban Tech Sustainability Fund I SCSP
✚
|
0.0 | |
|
Breyta Capital SPV I LP
✚
|
0.0 | |
|
BR Finley Holdings LLC
✚
|
0.0 | |
|
BRG 2017-I Oil & Gas Opportunity Fund, LP
✚
|
0.0 | |
|
Brewington James K
✚
|
0.0 | |
|
222 Loyola Investors QOF, LLC
✚
|
0.0 | |
|
KRE Longhorn Manager LLC
✚
|
0.0 | |
|
KRE NNN Member LLC
✚
|
0.0 | |
|
Bridge Buyout AP Fund I, LP
✚
|
0.0 |